Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SV Health Investors
Boston, Massachusetts, United States
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
SV Health Investors has backed or created over 200 life sciences and healthcare companies since its founding in 1993. Its portfolio has resulted in the approval of at least 26 therapeutics and six new drug classes for indications with unmet medical needs. Notable successes include Lynparza (olaparib), Macugen (pegaptanib), Entyvio (vedolizumab), Blincyto (blinatumomab), among others
- Therapeutic areas
- ImmunologyOncologyOphthalmology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateAptamerBicyclic peptidesGene therapy (including lentiviral-based)Cell therapy (e.g., natural killer cell engineering)CRISPR-based therapyAI-supported drug discovery
- Industry
- Investors
02
Partnerships
Cancer Research UK – strategic partnership to accelerate cancer medicine development via priority access to research outputs and co-investment into biotech fundsMultiple pharma partners through exits/acquisitions of portfolio companies by major pharmaceutical firms such as MSD/Merck & Co.
Beyond the preview
Go deeper on SV Health Investors.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SV Health Investors.